ImmuCell - 25 Year Stock Price History | ICCC

Historical daily share price chart and data for ImmuCell since 1995 adjusted for splits. The latest closing stock price for ImmuCell as of August 04, 2020 is 5.61.
  • The all-time high ImmuCell stock closing price was 11.05 on July 30, 2015.
  • The ImmuCell 52-week high stock price is 8.13, which is 44.9% above the current share price.
  • The ImmuCell 52-week low stock price is 3.70, which is 34% below the current share price.
  • The average ImmuCell stock price for the last 52 weeks is 5.02.
ImmuCell Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 4.8153 5.1500 6.3500 3.7900 5.6100 8.93%
2019 6.1081 7.0400 8.0900 4.8100 5.1500 -26.91%
2018 7.3511 8.2700 9.0300 6.4000 7.0465 -19.84%
2017 6.6063 5.9500 9.2300 5.2600 8.7900 47.73%
2016 6.6989 7.4300 8.2100 4.9000 5.9500 -21.09%
2015 7.1161 5.1200 11.0500 5.0200 7.5400 55.14%
2014 4.5186 4.2500 5.4500 3.4400 4.8600 13.84%
2013 3.9178 4.0000 4.9400 3.2800 4.2690 6.72%
2012 5.1370 4.8000 6.7500 3.7840 4.0001 -13.98%
2011 4.9931 3.2000 8.3400 3.0200 4.6500 45.31%
2010 3.4420 3.6500 4.3900 2.7100 3.2001 -13.74%
2009 2.5857 1.6600 4.2299 1.3800 3.7100 123.48%
2008 2.9930 3.5000 4.0000 1.6500 1.6601 -53.24%
2007 4.8873 5.9800 6.2300 3.2700 3.5500 -40.34%
2006 5.4601 5.1024 7.1500 4.5700 5.9500 13.33%
2005 4.7395 6.6560 6.6560 3.9100 5.2500 -26.68%
2004 4.3999 4.0300 9.3900 3.7000 7.1600 85.06%
2003 2.5525 1.7410 4.0800 1.7410 3.8690 130.30%
2002 2.5544 3.6000 3.6500 1.6000 1.6800 -53.97%
2001 2.8008 1.7500 4.7400 1.7500 3.6500 133.53%
2000 3.3696 2.5630 8.5000 1.5000 1.5630 -34.19%
1999 1.4813 1.2500 2.5000 1.0630 2.3750 90.00%
1998 1.9586 2.5000 2.6250 1.1250 1.2500 -49.37%
1997 2.5893 2.3750 3.2500 2.0630 2.4690 3.74%
1996 3.1341 2.3800 5.5000 2.0600 2.3800 -2.38%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.040B $0.014B
ImmuCell Corp. is a biotechnology company striving to build shareholder value by commercializing proprietary technologies and helping dairy and beef producers and their veterinarians manage disease and reproduction in their herds. The company is also conducting an open label, efficacy study of DiffGAM, a human application of its milk-derived passive antibodytechnology for use as an alternative to antibiotics in the treatment and/or prevention of Clostridium difficile-associated diarrhea.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $178.087B 33.45
Medtronic (MDT) Ireland $130.549B 21.20
Stryker (SYK) United States $71.817B 27.85
Boston Scientific (BSX) United States $53.175B 31.41
Lonza Group Ag (LZAGY) Switzerland $47.258B 0.00
Baxter (BAX) United States $42.098B 25.75
Terumo (TRUMY) Japan $29.607B 37.85
ResMed (RMD) United States $29.223B 46.12
EssilorLuxottica Societe Anonyme (ESLOY) France $28.452B 0.00
Zimmer Biomet Holdings (ZBH) United States $28.013B 17.63
Sunny Optical Technology (SNPTF) China $20.336B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.809B 0.00
Bio-Rad Laboratories (BIO) United States $15.744B 71.28
Insulet (PODD) United States $12.772B 1265.31
Quidel (QDEL) United States $12.326B 65.29
Shandong Weigao Medical Polymer (SHWGF) China $12.301B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
Perrigo (PRGO) Ireland $7.465B 13.36
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Canopy Growth (CGC) Canada $7.069B 0.00
Hill-Rom Holdings (HRC) United States $6.374B 15.82
Haemonetics (HAE) United States $4.386B 26.34
GW Pharmaceuticals (GWPH) United Kingdom $4.125B 0.00
Neogen (NEOG) United States $4.103B 68.55
ICU Medical (ICUI) United States $3.829B 27.93
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.787B 0.00
Envista Holdings (NVST) United States $3.527B 24.05
Abcam (ABCZY) $3.484B 0.00
Agios Pharmaceuticals (AGIO) United States $3.245B 0.00
NuVasive (NUVA) United States $2.857B 22.94
National Vision Holdings (EYE) United States $2.647B 45.79
TG Therapeutics (TGTX) United States $2.293B 0.00
AtriCure (ATRC) United States $1.871B 0.00
DFB Healthcare Acquisitions (AHCO) United States $1.649B 151.85
MacroGenics (MGNX) United States $1.445B 0.00
Aphria (APHA) Canada $1.413B 0.00
NanoString Technologies (NSTG) United States $1.402B 0.00
Cerus (CERS) United States $1.215B 0.00
Aurora Cannabis (ACB) Canada $1.203B 0.00
OraSure Technologies (OSUR) United States $1.189B 239.38
Vapotherm (VAPO) United States $1.128B 0.00
Meridian Bioscience (VIVO) United States $1.113B 41.92
Cardiovascular Systems (CSII) United States $1.102B 0.00
Owens & Minor (OMI) United States $1.072B 28.35
InMode (INMD) Israel $1.071B 22.64
PetIQ (PETQ) United States $1.055B 30.47
Phibro Animal Health (PAHC) United States $0.946B 18.86
Quanterix (QTRX) United States $0.914B 0.00
Omeros (OMER) United States $0.698B 0.00
BioLife Solutions (BLFS) United States $0.671B 191.00
Zynex (ZYXI) United States $0.656B 57.24
Eagle Pharmaceuticals (EGRX) United States $0.653B 46.78
Surmodics (SRDX) United States $0.651B 78.39
VAREX IMAGING (VREX) United States $0.625B 15.52
LeMaitre Vascular (LMAT) United States $0.609B 37.26
Lantheus Holdings (LNTH) United States $0.529B 12.31
Viemed Healthcare (VMD) United States $0.429B 38.07
Cytosorbents (CTSO) United States $0.346B 0.00
HEXO (HEXO) $0.336B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.329B 0.00
Utah Medical Products (UTMD) United States $0.294B 25.26
InfuSystems Holdings (INFU) United States $0.249B 137.67
Organigram Holdings (OGI) Canada $0.225B 0.00
Female Health (VERU) United States $0.199B 0.00
Chimerix (CMRX) United States $0.194B 0.00
Fonar (FONR) United States $0.160B 14.20
Bovie Medical (APYX) United States $0.159B 0.00
Exagen (XGN) United States $0.157B 0.00
Surface Oncology (SURF) United States $0.148B 0.00
Wound Management Technologies (SMTI) United States $0.135B 0.00
Liberty Health Sciences (LHSIF) Canada $0.130B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.119B 0.00
Chembio Diagnostics (CEMI) United States $0.118B 0.00
Capricor Therapeutics (CAPR) United States $0.110B 0.00
Evolus (EOLS) United States $0.102B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.091B 0.00
MTech Acquisition (KERN) United States $0.089B 0.00
Nephros (NEPH) United States $0.074B 0.00
United-Guardian (UG) United States $0.068B 15.87
Brainsway (BWAY) Israel $0.067B 0.00
Trinity Biotech (TRIB) Ireland $0.058B 0.00
GUARDION HEALTH (GHSI) United States $0.035B 0.00
Akers Biosciences Inc (AKER) United States $0.031B 0.00
FSD PHARMA INC (HUGE) Canada $0.029B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.009B 0.00
Senestech (SNES) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00